nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Rifampicin—leprosy	0.0939	0.11	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0939	0.11	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0775	0.0909	CbGbCtD
Triazolam—CYP3A7—Dapsone—leprosy	0.0775	0.0909	CbGbCtD
Triazolam—CYP3A5—Thalidomide—leprosy	0.0727	0.0853	CbGbCtD
Triazolam—CYP3A5—Rifampicin—leprosy	0.0705	0.0826	CbGbCtD
Triazolam—CYP2C8—Rifampicin—leprosy	0.0677	0.0794	CbGbCtD
Triazolam—CYP3A5—Dapsone—leprosy	0.0582	0.0682	CbGbCtD
Triazolam—CYP2C8—Dapsone—leprosy	0.0559	0.0655	CbGbCtD
Triazolam—CYP2C9—Thalidomide—leprosy	0.0488	0.0572	CbGbCtD
Triazolam—CYP2C9—Rifampicin—leprosy	0.0472	0.0554	CbGbCtD
Triazolam—CYP2C9—Dapsone—leprosy	0.039	0.0457	CbGbCtD
Triazolam—CYP3A4—Rifampicin—leprosy	0.0275	0.0322	CbGbCtD
Triazolam—CYP3A4—Dapsone—leprosy	0.0227	0.0266	CbGbCtD
Triazolam—GABRR3—peripheral nervous system—leprosy	0.00809	0.0838	CbGeAlD
Triazolam—GABRR2—peripheral nervous system—leprosy	0.00702	0.0726	CbGeAlD
Triazolam—GABRR1—peripheral nervous system—leprosy	0.00676	0.0699	CbGeAlD
Triazolam—GABRQ—nerve—leprosy	0.00631	0.0653	CbGeAlD
Triazolam—GABRR3—nerve—leprosy	0.00631	0.0653	CbGeAlD
Triazolam—GABRR2—nerve—leprosy	0.00547	0.0566	CbGeAlD
Triazolam—GABRR1—nerve—leprosy	0.00527	0.0545	CbGeAlD
Triazolam—TSPO—hindlimb—leprosy	0.00449	0.0464	CbGeAlD
Triazolam—TSPO—appendage—leprosy	0.00385	0.0398	CbGeAlD
Triazolam—Dysaesthesia—Thalidomide—leprosy	0.00288	0.0571	CcSEcCtD
Triazolam—GABRR3—eye—leprosy	0.00264	0.0273	CbGeAlD
Triazolam—GABRR2—eye—leprosy	0.00229	0.0237	CbGeAlD
Triazolam—Sexual dysfunction—Thalidomide—leprosy	0.00222	0.0441	CcSEcCtD
Triazolam—GABRR1—eye—leprosy	0.0022	0.0228	CbGeAlD
Triazolam—TSPO—blood vessel—leprosy	0.00214	0.0222	CbGeAlD
Triazolam—Muscular weakness—Dapsone—leprosy	0.00156	0.0309	CcSEcCtD
Triazolam—GABRR2—tendon—leprosy	0.00151	0.0157	CbGeAlD
Triazolam—GABRQ—nervous system—leprosy	0.00142	0.0147	CbGeAlD
Triazolam—GABRR3—nervous system—leprosy	0.00142	0.0147	CbGeAlD
Triazolam—Thinking abnormal—Thalidomide—leprosy	0.00136	0.027	CcSEcCtD
Triazolam—Hearing impaired—Thalidomide—leprosy	0.00131	0.026	CcSEcCtD
Triazolam—Coordination abnormal—Thalidomide—leprosy	0.00127	0.0252	CcSEcCtD
Triazolam—GABRG3—testis—leprosy	0.00127	0.0131	CbGeAlD
Triazolam—GABRG3—nervous system—leprosy	0.00124	0.0129	CbGeAlD
Triazolam—GABRR2—nervous system—leprosy	0.00123	0.0127	CbGeAlD
Triazolam—GABRR1—testis—leprosy	0.00121	0.0125	CbGeAlD
Triazolam—Depressed level of consciousness—Thalidomide—leprosy	0.0012	0.0239	CcSEcCtD
Triazolam—GABRR1—nervous system—leprosy	0.00118	0.0123	CbGeAlD
Triazolam—TSPO—eye—leprosy	0.00114	0.0118	CbGeAlD
Triazolam—Tinnitus—Dapsone—leprosy	0.00114	0.0226	CcSEcCtD
Triazolam—Lightheadedness—Thalidomide—leprosy	0.00111	0.0221	CcSEcCtD
Triazolam—Mental disability—Thalidomide—leprosy	0.00108	0.0214	CcSEcCtD
Triazolam—Euphoric mood—Thalidomide—leprosy	0.00107	0.0212	CcSEcCtD
Triazolam—GABRA4—tendon—leprosy	0.00107	0.011	CbGeAlD
Triazolam—Erythema—Dapsone—leprosy	0.00106	0.0211	CcSEcCtD
Triazolam—GABRD—testis—leprosy	0.00105	0.0109	CbGeAlD
Triazolam—GABRB3—eye—leprosy	0.00103	0.0107	CbGeAlD
Triazolam—GABRD—nervous system—leprosy	0.00103	0.0107	CbGeAlD
Triazolam—Deafness—Thalidomide—leprosy	0.00101	0.02	CcSEcCtD
Triazolam—TSPO—skin of body—leprosy	0.000992	0.0103	CbGeAlD
Triazolam—GABRG1—nervous system—leprosy	0.000991	0.0103	CbGeAlD
Triazolam—GABRA6—nervous system—leprosy	0.000985	0.0102	CbGeAlD
Triazolam—GABRA5—testis—leprosy	0.000974	0.0101	CbGeAlD
Triazolam—Amnesia—Thalidomide—leprosy	0.000961	0.0191	CcSEcCtD
Triazolam—GABRB1—nervous system—leprosy	0.000961	0.00995	CbGeAlD
Triazolam—GABRA5—nervous system—leprosy	0.000956	0.00989	CbGeAlD
Triazolam—Visual disturbance—Thalidomide—leprosy	0.000953	0.0189	CcSEcCtD
Triazolam—GABRA3—testis—leprosy	0.000907	0.00938	CbGeAlD
Triazolam—Osteoarthritis—Thalidomide—leprosy	0.000903	0.0179	CcSEcCtD
Triazolam—GABRA3—nervous system—leprosy	0.00089	0.00921	CbGeAlD
Triazolam—Affect lability—Thalidomide—leprosy	0.000889	0.0177	CcSEcCtD
Triazolam—GABRA4—nervous system—leprosy	0.000867	0.00897	CbGeAlD
Triazolam—Mood swings—Thalidomide—leprosy	0.000856	0.017	CcSEcCtD
Triazolam—Ataxia—Thalidomide—leprosy	0.000849	0.0169	CcSEcCtD
Triazolam—Tachycardia—Dapsone—leprosy	0.000846	0.0168	CcSEcCtD
Triazolam—Cramp muscle—Thalidomide—leprosy	0.000813	0.0162	CcSEcCtD
Triazolam—GABRE—tendon—leprosy	0.000809	0.00837	CbGeAlD
Triazolam—Muscular weakness—Thalidomide—leprosy	0.000797	0.0158	CcSEcCtD
Triazolam—Insomnia—Dapsone—leprosy	0.000784	0.0156	CcSEcCtD
Triazolam—TSPO—tendon—leprosy	0.000755	0.00781	CbGeAlD
Triazolam—GABRB2—testis—leprosy	0.000739	0.00765	CbGeAlD
Triazolam—GABRB2—nervous system—leprosy	0.000725	0.00751	CbGeAlD
Triazolam—GABRG2—nervous system—leprosy	0.000725	0.00751	CbGeAlD
Triazolam—Gastrointestinal pain—Dapsone—leprosy	0.000709	0.0141	CcSEcCtD
Triazolam—Drowsiness—Thalidomide—leprosy	0.000696	0.0138	CcSEcCtD
Triazolam—Abdominal pain—Dapsone—leprosy	0.000686	0.0136	CcSEcCtD
Triazolam—Stomatitis—Thalidomide—leprosy	0.000679	0.0135	CcSEcCtD
Triazolam—GABRE—testis—leprosy	0.00067	0.00693	CbGeAlD
Triazolam—GABRA2—nervous system—leprosy	0.000663	0.00686	CbGeAlD
Triazolam—GABRE—nervous system—leprosy	0.000657	0.0068	CbGeAlD
Triazolam—GABRA1—nervous system—leprosy	0.00064	0.00663	CbGeAlD
Triazolam—TSPO—testis—leprosy	0.000625	0.00647	CbGeAlD
Triazolam—TSPO—nervous system—leprosy	0.000613	0.00635	CbGeAlD
Triazolam—Visual impairment—Thalidomide—leprosy	0.000602	0.012	CcSEcCtD
Triazolam—Tinnitus—Thalidomide—leprosy	0.000583	0.0116	CcSEcCtD
Triazolam—GABRB3—testis—leprosy	0.000567	0.00587	CbGeAlD
Triazolam—GABRB3—nervous system—leprosy	0.000557	0.00577	CbGeAlD
Triazolam—Vomiting—Dapsone—leprosy	0.000551	0.0109	CcSEcCtD
Triazolam—Headache—Dapsone—leprosy	0.000543	0.0108	CcSEcCtD
Triazolam—Flatulence—Thalidomide—leprosy	0.000536	0.0106	CcSEcCtD
Triazolam—Tension—Thalidomide—leprosy	0.000534	0.0106	CcSEcCtD
Triazolam—Dysgeusia—Thalidomide—leprosy	0.000533	0.0106	CcSEcCtD
Triazolam—Nervousness—Thalidomide—leprosy	0.000528	0.0105	CcSEcCtD
Triazolam—Muscle spasms—Thalidomide—leprosy	0.000523	0.0104	CcSEcCtD
Triazolam—Nausea—Dapsone—leprosy	0.000515	0.0102	CcSEcCtD
Triazolam—Tremor—Thalidomide—leprosy	0.00051	0.0101	CcSEcCtD
Triazolam—Ill-defined disorder—Thalidomide—leprosy	0.000505	0.01	CcSEcCtD
Triazolam—Agitation—Thalidomide—leprosy	0.0005	0.00993	CcSEcCtD
Triazolam—Malaise—Thalidomide—leprosy	0.000491	0.00974	CcSEcCtD
Triazolam—Syncope—Thalidomide—leprosy	0.000488	0.00969	CcSEcCtD
Triazolam—Palpitations—Thalidomide—leprosy	0.000481	0.00954	CcSEcCtD
Triazolam—Loss of consciousness—Thalidomide—leprosy	0.000478	0.00949	CcSEcCtD
Triazolam—Hypertension—Thalidomide—leprosy	0.00047	0.00932	CcSEcCtD
Triazolam—Chest pain—Thalidomide—leprosy	0.000463	0.0092	CcSEcCtD
Triazolam—Anxiety—Thalidomide—leprosy	0.000462	0.00916	CcSEcCtD
Triazolam—Discomfort—Thalidomide—leprosy	0.000458	0.00908	CcSEcCtD
Triazolam—Dry mouth—Thalidomide—leprosy	0.000453	0.00899	CcSEcCtD
Triazolam—Confusional state—Thalidomide—leprosy	0.000448	0.00889	CcSEcCtD
Triazolam—Oedema—Thalidomide—leprosy	0.000444	0.00881	CcSEcCtD
Triazolam—Shock—Thalidomide—leprosy	0.000437	0.00867	CcSEcCtD
Triazolam—Tachycardia—Thalidomide—leprosy	0.000433	0.0086	CcSEcCtD
Triazolam—Hyperhidrosis—Thalidomide—leprosy	0.000429	0.00852	CcSEcCtD
Triazolam—CYP2C8—testis—leprosy	0.000429	0.00444	CbGeAlD
Triazolam—Anorexia—Thalidomide—leprosy	0.000423	0.0084	CcSEcCtD
Triazolam—Insomnia—Thalidomide—leprosy	0.000402	0.00797	CcSEcCtD
Triazolam—Paraesthesia—Thalidomide—leprosy	0.000399	0.00792	CcSEcCtD
Triazolam—Dyspnoea—Thalidomide—leprosy	0.000396	0.00786	CcSEcCtD
Triazolam—Somnolence—Thalidomide—leprosy	0.000395	0.00784	CcSEcCtD
Triazolam—Decreased appetite—Thalidomide—leprosy	0.000386	0.00766	CcSEcCtD
Triazolam—Fatigue—Thalidomide—leprosy	0.000383	0.0076	CcSEcCtD
Triazolam—Pain—Thalidomide—leprosy	0.00038	0.00754	CcSEcCtD
Triazolam—Constipation—Thalidomide—leprosy	0.00038	0.00754	CcSEcCtD
Triazolam—Feeling abnormal—Thalidomide—leprosy	0.000366	0.00726	CcSEcCtD
Triazolam—Gastrointestinal pain—Thalidomide—leprosy	0.000363	0.00721	CcSEcCtD
Triazolam—Abdominal pain—Thalidomide—leprosy	0.000351	0.00697	CcSEcCtD
Triazolam—Hypersensitivity—Thalidomide—leprosy	0.000327	0.00649	CcSEcCtD
Triazolam—Asthenia—Thalidomide—leprosy	0.000319	0.00632	CcSEcCtD
Triazolam—Pruritus—Thalidomide—leprosy	0.000314	0.00624	CcSEcCtD
Triazolam—Diarrhoea—Thalidomide—leprosy	0.000304	0.00603	CcSEcCtD
Triazolam—Dizziness—Thalidomide—leprosy	0.000294	0.00583	CcSEcCtD
Triazolam—CYP3A4—nervous system—leprosy	0.000285	0.00295	CbGeAlD
Triazolam—Vomiting—Thalidomide—leprosy	0.000282	0.0056	CcSEcCtD
Triazolam—Dermatitis—Thalidomide—leprosy	0.00028	0.00555	CcSEcCtD
Triazolam—Headache—Thalidomide—leprosy	0.000278	0.00552	CcSEcCtD
Triazolam—Nausea—Thalidomide—leprosy	0.000264	0.00524	CcSEcCtD
